The Sugen 5416/hypoxia mouse model of pulmonary hypertension revisited: long-term follow-up

Abstract. The combination of a vascular endothelial growth factor receptor antagonist, Sugen 5416 (SU5416), and chronic hypoxia is known to cause pronounced pulmonary hypertension (PH) with angioobliterative lesions in rats and leads to exaggerated PH in mice as well. We sought to determine whether...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Pulm Circ
Prif Awduron: Vitali, Sally H., Hansmann, Georg, Rose, Chase, Fernandez-Gonzalez, Angeles, Scheid, Annette, Mitsialis, S. Alex, Kourembanas, Stella
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: University of Chicago Press 2014
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4278622/
https://ncbi.nlm.nih.gov/pubmed/25610598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/678508
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg